Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
about
Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloofDrug-induced diabetes mellitusBeta-blockers for preventing stroke recurrenceBeta-blockers for hypertensionAntihypertensive agents for preventing diabetic kidney diseaseBeta-blockers for hypertensionBeta-blockers for preventing stroke recurrenceThiazide diuretics and the risk of hip fractureLong-term non-pharmacological weight loss interventions for adults with prediabetesThiazide diuretics and the risk of hip fractureAntihypertensive agents for preventing diabetic kidney diseaseRe-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysisDebate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!Debate: does it matter how you lower blood pressure?Back to thiazide-diuretics for hypertension: reflections after a decade of irrational prescribingDiuretics: again the first step in the treatment of most patients with hypertensionRole of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial HypertensionDietary inorganic nitrate: From villain to hero in metabolic disease?Obesity associated hypertension: new insights into mechanismβ-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literatureBlood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analysesEffect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trialsStroke prevention in diabetes and obesityAmlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J)Fixed combination of losartan and hydrochlorothiazide and reduction of risk of strokeProgressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trialUrinary albumin : creatinine ratio predicts prediabetes progression to diabetes and reversal to normoglycemia: role of associated insulin resistance, inflammatory cytokines and low vitamin DAngiotensin II inhibits insulin-stimulated phosphorylation of eukaryotic initiation factor 4E-binding protein-1 in proximal tubular epithelial cellsLosartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytesLong-term systemic angiotensin II type 1 receptor blockade regulates mRNA expression of dorsomedial medulla renin-angiotensin system componentsNovel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease.Beta-blockers for hypertension.Why not prescribe the best drugs for hypertension now?Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease.Treatment of hypertension in obese patients.Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of HypertensionComparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis.Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study.Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study
P2860
Q21246039-C7FCA043-00BE-40FA-B3A9-FCDD23F0C3CBQ22306015-921C0661-8BAB-4FEB-B85E-C34349A02FEEQ24193102-C4953B54-8E7B-4692-BBF2-DB552457A521Q24201511-7C68D7FA-C21C-49CF-B0EC-06AF150BD93CQ24202090-1E01D8AA-4E63-4541-9738-02794718FB96Q24202812-E89FCFBD-B4D3-4934-832A-7F2066A90FBBQ24202904-139ACBC5-E48C-4A04-A70E-04AAF1BFFA40Q24236268-346BDE14-B4C1-4C01-A707-EE38EF4177E1Q24244294-E2BA02AF-57E8-4766-A57A-59D301ABC75AQ24245500-7031CAB2-CD16-46D3-93C9-E2DD8D53B9CFQ24245557-1081E2E6-5AC1-429D-BFDC-37FF0B5C4446Q24545775-7F0F10C4-32A9-4CFD-B02C-B0585366832DQ24792379-516F30EA-EE70-4186-BC44-3CB259419AACQ24792999-5D7BD3D8-649F-44FA-B219-52B892170B13Q24805075-BDBB872E-B532-46C2-8719-A214A8D52850Q24806951-5C77D8EE-9E8A-4B58-A1AE-B757E518CA68Q26747017-A0C3D6AC-7824-4C01-AFEC-F8B5F910E5C1Q26801360-ACF6B4C0-2241-4F22-8DC4-370CC8A686A4Q26827389-AB3EFD7C-F418-4B0B-A1E3-B1F82309C53FQ26861630-87178189-6396-46BD-B966-6D73D0C7E744Q26996563-7AC6B9FB-6A9B-43AE-8717-C7856D9C6B21Q28087109-C015CBBF-E75A-4EE4-974B-3E45819C0F73Q28200179-57FA4229-5970-4319-A0B0-A1D2867D79A9Q28200627-215EB5ED-F383-431B-B107-9ED689D6F3FCQ28219593-784C2E70-8913-4D72-B902-C770D094A1E9Q28286410-724A8697-6C56-42E3-B5B8-DD77FA8581ECQ28302247-C3D42A5C-6052-46F8-A32A-A1F9F5B0EAAFQ28363300-716895A0-7DC2-4D11-9741-FB6D62B69BEAQ28573802-5FDCA2A0-EEAF-4424-990B-F1B74205538AQ28742760-0305AFBA-466F-4021-9BF2-482172F8BB03Q30235583-384B70EA-E534-48E7-89AA-D48CA7D52153Q30238911-27B35C2C-FEA3-4C02-B661-9E856999B6A0Q30333019-C31C9445-D536-4B32-A8BF-37805249ACD3Q30381121-5ED36094-B23F-4521-8362-3C236F080D23Q30429298-49D46F43-0759-4308-A9BB-DA57E3722C27Q30499043-749228C4-4A05-46D6-A4DB-855C5A846AB8Q30499045-A777C4FB-DE3C-4CAB-90A5-3397E1BE44C2Q30514101-8F892448-F479-4959-B0D2-23B80D9F80B8Q30598702-CCCE768D-73FF-4699-B278-A2DC85A97926Q30711948-D189E4CA-525B-4365-AB2D-34061DEAC5E5
P2860
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Effect of angiotensin-converti ...... ject (CAPPP) randomised trial.
@ast
Effect of angiotensin-converti ...... ject (CAPPP) randomised trial.
@en
Effect of angiotensin-converti ...... e Captopril Prevention Project
@nl
type
label
Effect of angiotensin-converti ...... ject (CAPPP) randomised trial.
@ast
Effect of angiotensin-converti ...... ject (CAPPP) randomised trial.
@en
Effect of angiotensin-converti ...... e Captopril Prevention Project
@nl
prefLabel
Effect of angiotensin-converti ...... ject (CAPPP) randomised trial.
@ast
Effect of angiotensin-converti ...... ject (CAPPP) randomised trial.
@en
Effect of angiotensin-converti ...... e Captopril Prevention Project
@nl
P2093
P1433
P1476
Effect of angiotensin-converti ...... ject (CAPPP) randomised trial.
@en
P2093
A Niklason
B E Karlberg
J E Björck
K Luomanmäki
L H Lindholm
L Niskanen
P304
P356
10.1016/S0140-6736(98)05012-0
P407
P50
P577
1999-02-01T00:00:00Z